Genomics/Transcriptomics

Our Genetics GIGA platform is at the forefront of technological innovation and assay development. It offers expert services in high-throughput genomic assays, including array- and NGS-based NSP genotyping, variant detection, transcriptome and epigenome analyses.

In addition, the Genetic Department of the CHU has developed a large expertise in the diagnosis of genetic diseases, including genetic predisposition to cancer, as well as the diagnosis of acquired genetic and epigenetic features in cancers in pediatric and adult patients, and in the analysis of acquired genetic anomalies in diverse malignant tumors (leukemia’s, lymphomas and various solid tumors). The genetic department is one of the 8 Centers for Human Genetics in Belgium and we are BELAC accredited for diagnostic tests for genetic diseases and cancer (ISO 15189).

We are ready to help you in various projects such as patient characterization, metabolic profiling during clinical studies, exploration of SNPs or high throughput DNA sequencing in search for treatment targets and/or markers predictive of response or resistance.

Contact [info@b2h.be] us to discuss how these capabilities can forward your projects! We will help you develop tailored solutions.

Related articles

PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

Liège (Belgium), 21st January 2019. PDC*line Pharma is delighted to announce, that the company is now accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for the Quality Control and Release activities of its anticancer agent PDC*lung, intended for the treatment of patients with lung cancer.  PDC*line Pharma is developing a new

Read more
PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer immunotherapy

First Congress in Health Simulation

The Medical Simulation Center of the University of Liège organizes its first congress in Health Simulation: “Towards evidence-based simulation”. Event will be held on Thursday, March 28th, 2019 in the faculty of medicine amphitheatres of Liège University, located on Sart-Tilman campus. Several themes will be discussed: Evidence-based Innovations and advances in simulation Medical education –

Read more
First Congress in Health Simulation

New University Certificate for clinical trials

The Clinical Sciences Department of the Medicine Faculty of the University of Liège organizes from the academic year 2018-2019 a University Certificate in clinical trials. More information is available in this folder

Read more
New University Certificate for clinical trials